Physician profile
Deepali Patel
NPI 1447736756
$984.29
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $143 · 2021: $143 · 2022: $267 · 2023: $134 · 2024: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $287.88 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $92.94 | 2024 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $86.06 | 2019-2023 | Flarex |
| Alcon Vision LLC | $79.15 | 2023-2024 | Total30, Precision 1, Precision 7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.11 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $57.31 | 2021-2022 | |
| Shire North American Group INC | $54.63 | 2019 | |
| Bausch & Lomb Americas INC. | $47.32 | 2022-2024 | Vyzulta, Lotemax Sm, Prolensa |
| Oyster Point Pharma, INC. | $44.09 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $32.98 | 2020 | |
| Aerie Pharmaceuticals, INC. | $28.48 | 2020-2021 | |
| Allergan, INC. | $25.93 | 2020 | |
| Biotissue Holdings INC. | $18.02 | 2023 | |
| Mallinckrodt Hospital Products INC. | $15.05 | 2024 | Acthar |
| Abbvie INC. | $15.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $14.87 | 2019 | |
| Sun Pharmaceutical Industries INC. | $13.97 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.